Evidence map›Paper›PMID 39517393›Full record

ArticleHealthcare (Basel, Switzerland)2024

Exploring the Challenges and Solutions in Conducting Clinical Trials in Saudi Arabia: A Qualitative Study Perspective.

Basim Alsaywid, Dana Khafagi, Alaa Bashaikh, Abdulaziz Alsada, Reema Bawazir, Rasal Alotaibi, Lina Alharbi, Rama Alqarni, Rana Alhuthayfi, Hana Alhumud and 5 more

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Basim AlsaywidEducation and Research Skills Directory, Saudi National Institute of Health, Riyadh 12382, Saudi Arabia.ORCID 0000-0002-2277-5486
Dana KhafagiRadiology Department, College of Applied Medical Sciences, University of Jeddah, Jeddah 21959, Saudi Arabia.
Alaa BashaikhCTI Clinical Trial and Consulting Services, Riyadh 21959, Saudi Arabia.
Abdulaziz AlsadaCollege of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Reema BawazirCollege of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Rasal AlotaibiCollege of Nursing, Jazan University, Jazan 45142, Saudi Arabia.ORCID 0009-0006-0756-3473
Lina AlharbiCollege of Medicine, University of Jeddah, Jeddah 21959, Saudi Arabia.ORCID 0009-0002-9464-9902
Rama AlqarniCollege of Nursing, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard, Health Affairs, Jeddah 11426, Saudi Arabia.
Rana AlhuthayfiFaculty of Medicine, King Abdulaziz University, Jeddah 21551, Saudi Arabia.
Hana AlhumudEducation and Research Skills Directory, Saudi National Institute of Health, Riyadh 12382, Saudi Arabia.
Shadell AlGhamdiCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard, Health Affairs, Jeddah 11426, Saudi Arabia.
Mohamed Anwar KhanCollege of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard, Health Affairs, Jeddah 11426, Saudi Arabia.
Wadha AlshaliEducation and Research Skills Directory, Saudi National Institute of Health, Riyadh 12382, Saudi Arabia.
Eman Al MutairiEducation and Research Skills Directory, Saudi National Institute of Health, Riyadh 12382, Saudi Arabia.
Miltiadis D LytrasEffat College of Engineering, Effat University, Jeddah 21478, Saudi Arabia.ORCID 0000-0002-7281-5458

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionClinical trials are crucial for advancing medical knowledge and improving healthcare outcomes. Despite an increase in research publications in Saudi Arabia, clinical trial productivity has lagged behind. Understanding the barriers to conducting clinical trials in Saudi Arabia is essential. This study aims to explore the challenges and propose solutions for improving clinical trial capacity in the Kingdom. Specifically, we aim to develop national strategies to enhance clinical trial infrastructure, identify educational needs, and suggest ways to strengthen research education and training in Saudi Arabia.

methodsThe study utilized a qualitative research design with a grounded theory approach. Participants were recruited through purposive sampling, including clinical trial professionals from Riyadh, Jeddah, and Al Khobar, who participated in three half-day workshops. Discussions focused on required skillsets, barriers to conducting trials, improvement recommendations, gaps in research education, and strategies for the Saudi National Institute of Health (SNIH) to support clinical trials. Data were collected through pre-workshop surveys and focus group discussions, and thematic analysis was employed to identify common themes.

resultsA total of 35 participants, mainly from the government sector (67%), attended the workshops. Physicians represented the largest professional group (31%), with the majority being Saudi nationals (83%) and engaged in clinical practice (65%). The study identified key challenges, including limited resources (82%), inadequate infrastructure (82%), time constraints (80%), and insufficient funding (80%). While satisfaction with educational programs was mixed, a need for improved infrastructure and support for clinical trials in Saudi Arabia was evident. The focus group discussions further highlighted the importance of research competency, identifying 11 essential domains such as research methodology, data management, and project leadership. Nine major challenges were noted, including funding, infrastructure, and collaboration deficits. A total of 38 recommendations were proposed to address these challenges and enhance the national clinical trial ecosystem.

conclusionsThis study underscores the importance of addressing the challenges in conducting clinical trials in Saudi Arabia through targeted educational programs, training initiatives, and enhanced support from the SNIH. By implementing strategies that focus on funding, resources, training, and collaboration, Saudi Arabia can significantly advance its clinical trial landscape, improve research quality and efficiency, and position itself as a leader in global health research.

Indexed as

capacity buildingchallengesclinical trialscompetencyinitiativesnational strategiesqualitative studyresearch educationSaudi ArabiaskillsetsSNIHsolutionsthematic analysis

Identifiers

PMID39517393
PMCPMC11545250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.